Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts

Abstract

p19ARF encoded by the INK4a tumor suppressor gene locus functions upstream of p53 to induce cell cycle arrest. p19ARF can interact with MDM2 and p53 in cells ectopically overexpressing these three components, but the biochemical cascades from p19ARF to cell cycle arrest has not been fully elucidated. In this study, we generated stably transfected NIH3T3 cells that express exogenous p19ARF under the control of a heavy metal-inducible metalothionine promoter. Cells arrested in G1 by ectopically expressed p19ARF contained considerably reduced G1 cyclin dependent kinase (cdk2 and cdk4) activities. The expression of cyclin A (a regulatory subunit of cdk2) markedly decreased, while cyclin D1, the major cdk4 partner in fibroblasts, expressed at a slightly higher level and formed complexes with cdk2 and cdk6 in addition to cdk4. Induction of p19ARF activated p53 by increasing its stability, and allowed the expression of p21Cip1, which bound to all of the cyclin D1-cdk complexes (cyclin D1-cdk2, -cdk4, and -cdk6) thereby inhibiting their kinase activities. p19ARF formed complexes with several cellular proteins including mouse MDM2. The majority of MDM2 was found in the complex with p19ARF, while no p53 was detected in association with p19ARF. Thus, we propose that p19ARF neutralizes MDM2 by sequestration from p53, which results in activation of p53, inhibition of G1 cyclin-cdk activities, and G1 arrest.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Brown DR, Thomas CA and Deb SP. . 1998 EMBO J. 17: 2513–2525.

  • Chen C and Okayama H. . 1987 Mol. Cell. Biol. 7: 2745–2752.

  • Cook DM, Hinkes MT, Bernfield M and Rauscher III FJ. . 1996 Oncogene 13: 1789–1799.

  • Della Valle V, Duro D, Bernard O and Larsen C-J. . 1997 Oncogene 15: 2475–2481.

  • Dunphy WG. . 1994 Trends. Cell Biol. 4: 202–207.

  • Gottlieb MT and Oren M. . 1996 Biochim. Biophys. Acta 1287: 77–102.

  • Haber DA. . 1997 Cell 91: 555–558.

  • Hall M and Peters G. . 1996 Adv. Cancer Res. 68: 67–108.

  • Haupt Y, Maya R, Kazaz A and Oren M. . 1997 Nature 387: 296–299.

  • Hermeking H, Lengauer C, Polyak K, He T-C, Zhang L, Thiagalingam S, Kinzler KW and Vogelstein B. . 1997 Mol. Cell 1: 3–11.

  • Honda R, Tanaka H and Yasuda H. . 1997 FEBS Letts. 420: 25–27.

  • Hunter T and Pines J. . 1994 Cell 79: 573–582.

  • Jones SN, Roe AE, Donehower LA and Bradley A. . 1995 Nature 378: 206–208.

  • Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ. . 1997 Cell 91: 649–659.

  • Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF and Sherr CJ. . 1998 Proc. Natl. Acad. Sci. USA 95: 8292–8297.

  • King RW, Jackson PK and Kirschner MW. . 1994 Cell 79: 563–571.

  • Ko LJ and Prives C. . 1996 Genes Dev. 10: 1054–1072.

  • Kubbutat MH, Jones SN and Vousden KH. . 1997 Nature 387: 299–303.

  • LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A and Harlow ED. . 1997 Genes Dev. 11: 847–862.

  • Leng P, Brown DR, Deb S and Deb SP. . 1995 Int. J. Oncol. 6: 251–259.

  • Levine AJ. . 1997 Cell 88: 323–331.

  • Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ and Sidransky D. . 1995 Cancer Res. 55: 2995–2997.

  • Marechal V, Elenbaas B, Piette J, Nicolas JC and Levine AJ. . 1994 Mol. Cell. Biol. 14: 7414–7420.

  • Martin K, Trouche D, Hagemeler C, Sorensen TS, LaThangue NB and Kouzarides T. . 1995 Nature 375: 691–694.

  • Matsushime H, Roussel MF, Ashmun RA and Sherr CJ. . 1991 Cell 65: 701–713.

  • Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ and Kato J-y. . 1994 Mol. Cell. Biol. 14: 2066–2076.

  • Momand J, Zambetti GP, Olson DC, George D and Levine AJ. . 1992 Cell 69: 1237–1245.

  • Montes de Oca Luna R, Wagner DS and Lozano G. . 1995 Nature 378: 203–206.

  • Piette J, Neel H and Marechal V. . 1997 Oncogene 15: 1001–1010.

  • Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee H-W, Cordon-Cardo C and DePinho RA. . 1998 Cell 92: 713–723.

  • Quelle DE, Ashmun RA, Shurtleff SA, Kato J-y, Bar-Sagi D, Roussel MF and Sherr CJ. . 1993 Genes Dev. 7: 1559–1571.

  • Quelle DE, Cheng M, Ashmun RA and Sherr CJ. . 1997 Proc. Natl. Acad. Sci. USA 94: 669–673.

  • Quelle DE, Zindy F, Ashmun RA and Sherr CJ. . 1995 Cell 83: 993–1000.

  • Serrano M, Hannon GJ and Beach D. . 1993 Nature 366: 704–707.

  • Sheaff RJ and Roberts JM. . 1995 Curr. Biol. 5: 28–31.

  • Sherr CJ. . 1996 Science 274: 1672–1677.

  • Sherr CJ and Roberts JM. . 1995 Genes Dev. 9: 1149–1163.

  • Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G and Kamb A. . 1995 Cancer Res. 55: 2988–2994.

  • Weinberg RA. . 1995 Cell 81: 323–330.

  • Xiao ZH, Chen J, Levine AJ, Modjthedi N, Xing J, Sellers WR and Livingston DM. . 1995 Nature 375: 694–698.

  • Zhang Y, Xiong Y and Yarbrough WG. . 1998 Cell 92: 725–734.

Download references

Acknowledgements

We thank Drs AJ Levine, CJ Sherr, and J Fujisawa for the plasmids and antibodies. This work was supported by Grants-in-Aid for Scientific Research and for Cancer Research from the Ministry of Education, Science, and Culture of Japan.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurokawa, K., Tanaka, T. & Kato, Jy. p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts. Oncogene 18, 2718–2727 (1999). https://doi.org/10.1038/sj.onc.1202628

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202628

Keywords

This article is cited by

Search

Quick links